The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
Open accessAbstract
Improvement of ovarian cancer patient outcome requires well-characterized animal models in which to evaluate novel therapeutics. Xenograft models are frequently used, but with little discussion of disease histology. The objectives of this study were to inject 11 ovarian cancer cell lines intraperitoneally (ip), and a subset intrabursally (ib; orthotopic), into nude mice and to analyze the resulting pathologies. Eight of 11 lines injected ip formed tumors within 3 months at variable rates with the following histological subtype distribution: one endometrioid, one serous, one clear cell, and five undifferentiated. Only mice injected with A2780-cp cells presented with ovarian-specific metastases (11 of 88), and the survival time of these animals was significantly shorter, which may be attributed to the higher proliferation rate as determined by Ki67 positivity. Additional analysis of the influence of the ovarian microenvironment on cell characteristics was conducted with ib injection of two cell lines (OVCA 429 and ES-2). The site of injection did not affect the tumor histology, the effect on proliferation was cell-type dependent, and the tumor take rate (cell survival) was negatively affected for OVCA 429 cells. The animal models described herein represent histologically distinct models of both early and late stage ovarian cancer useful for evaluation of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23
Fogh, J., Fogh, J. M., & Orfeo, T. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.1.221 · Cited by 1,599
Fogh, J., & Trempe, G. (1975) · Human Tumor Cells in Vitro · doi:10.1007/978-1-4757-1647-4_5 · Cited by 1,005
HETEROTRANSPLANTATION OF A HUMAN MALIGNANT TUMOUR TO “NUDE” MICE
Rygaard, J., & Poulsen, C. O. (1969) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1969.tb04520.x · Cited by 724
Kim, J., Yu, W., Kovalski, K., & Ossowski, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81478-6 · Cited by 468
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
Comparative properties of five human ovarian adenocarcinoma cell lines.
Buick, R. N., Pullano, R., & Trent, J. M. (1985) · PubMed · Cited by 349
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters
Entschladen, F., Drell, T. L., Lang, K., Joseph, J., & Zaenker, K. S. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01431-7 · Cited by 334
Circulating DNA: a new diagnostic gold mine?
Ziegler, A., Zangemeister-Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 228
Fu, X., & Hoffman, R. M. (1993) · PubMed · Cited by 193
Hao, X., Sun, B., Hu, L., Lähdesmäki, H., Dunmire, V., Feng, Y., Zhang, S., Wang, H., Wu, C., Wang, H., et al. (2004) · Cancer · doi:10.1002/cncr.20095 · Cited by 168
Cell-mediated immunity to human malignant cells
DiSaia, P. J., Sinkovics, J. G., Rutledge, F. N., & Smith, J. P. (1972) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(72)90109-3 · Cited by 153
Maire, F., Micard, S., Hammel, P. R., Voitot, H., Lévy, P., Cugnenc, P., Ruszniewski, P. B., & Laurent‐Puig, P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600475 · Cited by 142
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
Andrews, P. A., & Albright, K. D. (1992) · PubMed · Cited by 120
Berchuck, A., Rodriguez, G., Olt, G. J., et al. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91697-9 · Cited by 111
Effect ofmts1 (S100A4) expression on the progression of human breast cancer cells
Grigorian, M., Ambartsumian, N. S., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G. P., & Lukanidin, E. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6<816::aid-ijc10>3.0.co;2-# · Cited by 108
Möbus, V. J., Gerharz, C. D., Press, U., Moll, R., Beck, T., Mellin, W., Pollow, K., Knapstein, P. O., & Kreienberg, R. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520115 · Cited by 101
Varney, M. L., Li, A., Davé, B. J., Bucana, C. D., Johansson, S. L., & Singh, R. K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000006814.48627.bd · Cited by 101
Lau, D. H., Lewis, A. D., Ehsan, M. N., & Sikic, B. I. (1991) · PubMed · Cited by 97
Circulating nucleic acids in plasma or serum
Anker, P., Lyautey, J., Lederrey, C., & Stroun, M. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00666-0 · Cited by 95
Yanagawa, R., Furukawa, Y., Tsunoda, T., Kitahara, O., Kameyama, M., Murata, K., Ishikawa, O., & Nakamura, Y. (2001) · Neoplasia · doi:10.1038/sj.neo.7900185 · Cited by 91
Reinholz, M. M., Iturria, S. J., Ingle, J. N., & Roche, P. C. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016339120506 · Cited by 86
Verschraegen, C. F., Hu, W., Du, Y., Mendoza, J. T., Early, J., Deavers, M. T., Freedman, R. S., Bast, R. C., Kudelka, A. P., Kavanagh, J. J., et al. (2003) · PubMed · Cited by 56
Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expression
Molthoff, C. F. M., Calame, J. J., Pinedo, H. M., & Boven, E. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470114 · Cited by 50
Circulating DNA in Plasma and Serum: Biology, Preanalytical Issues and Diagnostic Applications
Lui, Y. Y.-N., & Lo, Y. M. D. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.169 · Cited by 47
Margalit, O., Eisenbach, L., Amariglio, N., Kaminski, N., Harmelin, A., Pfeffer, R., Shohat, M., Rechavi, G., & Berger, R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600977 · Cited by 45
Håkan Andersson, S. L. (2000) · Acta Oncologica · doi:10.1080/028418600750063820 · Cited by 42
A Human Ovarian Carcinoma Murine Xenograft Model Useful for Preclinical Trials
Elkas, J. C., Baldwin, R. L., Pegram, M. D., Tseng, Y., Slamon, D. J., & Karlan, B. Y. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6819 · Cited by 37
Wong, W. S. F., Wong, Y., Ng, Y. T. A., Huang, P. D., Chew, E. C., Ho, T. H., & Chang, M.-C. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90008-9 · Cited by 34
Burbridge, M. F., Kraus‐Berthier, L., Naze, M., Pierré, A., Atassi, G., & Guilbaud, N. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.6.1155 · Cited by 21
Kraeber‐Bodéré, F., Mishra, A. K., Thédrez, P., Faivre-Chauvet, A., Bardiès, M., Imai, S., Boterff, J. L., & Chatal, J. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00833392 · Cited by 20
Tumor-specific DNA in plasma of breast cancer patients
Shao, Z., & Nguyen, M. T. N. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200204000-00003 · Cited by 15
Cited by
The Mammalian Ovary from Genesis to Revelation
Edson, M. A., Nagaraja, A. K., & Matzuk, M. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0012 · Cited by 820
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Cho, J. H., Collins, J. J., & Wong, W. W. (2018) · Cell · doi:10.1016/j.cell.2018.03.038 · Cited by 682
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9692 · Cited by 441
Rattan, R., Graham, R. P., Maguire, J. L., Giri, S., & Shridhar, V. (2011) · Neoplasia · doi:10.1593/neo.11148 · Cited by 316
Metadata
- Authors
- Shaw, T. J., Senterman, M. K., Dawson, K., Crane, C. A., & Vanderhyden, B. C.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 10
- Issue
- 6
- Pages
- 1032-1042
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2051239163
- Cited by
- 278
- References
- 32
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.